Cargando…
Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1
Notch signaling is minimally active in neuroendocrine (NE) cancer cells. While histone deacetylase inhibitors (HDACi) suppress NE cancer growth by inducing Notch, the molecular mechanism underlying this interplay has not yet been defined. NE cancer cell lines BON, H727, and MZ‐CRC‐1 were treated wit...
Autores principales: | Jang, Samuel, Jin, Haining, Roy, Madhuchhanda, Ma, Alice L., Gong, Shaoqin, Jaskula‐Sztul, Renata, Chen, Herbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603840/ https://www.ncbi.nlm.nih.gov/pubmed/28776955 http://dx.doi.org/10.1002/cam4.1151 |
Ejemplares similares
-
Histone deacetylase inhibitor thailandepsin-A activates Notch signaling and suppresses neuroendocrine cancer cell growth in vivo
por: Jang, Samuel, et al.
Publicado: (2017) -
Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line
por: Tesfazghi, Sara, et al.
Publicado: (2013) -
Chrysin suppresses the achaete-scute complex-like1 and alters the neuroendocrine phenotype of carcinoids
por: Somnay, Yash R., et al.
Publicado: (2015) -
Pulmonary Carcinoid Surface Receptor Modulation Using Histone Deacetylase Inhibitors
por: Guenter, Rachael E., et al.
Publicado: (2019) -
2018 Synaptic vesicle 2 receptors as a novel targets for
neuroendocrine cancer therapy
por: Jaskula-Sztul, Renata, et al.
Publicado: (2018)